HETEROCYCLES, Vol. 82, No. 2, 2011
1673
814, 793, 735, 696, 666; 1H NMR (400 MHz, CDCl3): "= 7.69 (2H, dd, J=1.6 Hz, 8.0 Hz), 7.33 -7.14 (17H,
m), 4.62 (1H, d, J=12.0 Hz), 4.55 (2H, s), 4.53 (1H, d, J=11.6 Hz), 4.47 (2H, s), 4.10 (1H, dd, J=4.0 Hz, 10.4
Hz), 4.00 (1H, dd, J=6.0 Hz, 10.4 Hz), 3.70-3.65 (2H, m), 3.63-3.43 (10H, m), 3.44 (2H, dd, J=3.2 Hz, 5.6
Hz), 3.40 (1H, dd, J=5.6 Hz, 10.0 Hz), 2.34 (3H, s), 2.10-2.00 (1H, brs, OH); 13C-NMR (100 MHz, CDCl3):
"= 144.8, 138.4, 138.3, 137.8, 132.9, 129.8, 128.5, 128.4, 128.0, 127.80, 127.76, 127.72, 127.70, 127.6, 77.9,
76.9, 76.7, 75.4, 72.4, 72.3, 72.1, 71.6, 71.5, 70.2, 69.4, 62.7, 21.6; LRMS (ESI+): m/z (%) = 687 ([M+Na]+,
100); HRMS (ESI+): calcd for C37H44NaO9S: 687.2598; found: 687.2615.
C3-symmetric 1,5,9-O-Tribenzyl-3,7,11-trioxacyclododecane-1,7,11-triol (1-C3). To a solution of NaH
(60% activity, 24.0 mg, 0.6 mmol) in THF (24 mL) was added dropwise with a syringe pump the THF (6
mL) solution of tri-glycerol mono-tosylate (22) (100 mg, 0.15 mmol) at 80˚C within 3 h. After additional
stirring for 14 h, the reaction mixture was quenched with brine. The aq. solution was extracted with
EtOAc and the organic phase was washed with water and brine, and dried (Na2SO4). Filtration,
concentration and preparative silica gel TLC purification (hexane/EtOAc, 3/2) to afford 1-C3 (41.4 mg,
0.084 mmol, 56%) of as a colorless oil: Rf = 0.24 (hexane/EtOAc, 3/2); IR (neat, cm!1): 2865, 1497, 1454,
1
1355, 1304, 1273, 1208, 1099, 1028, 986, 948, 910, 836, 733, 695; H NMR (400 MHz, CDCl3): "=
7.38-7.25 (15H, m), 4.61 (6H, s), 3.74 (6H, dd, J = 3.6, 9.6 Hz), 3.73 (3H, dd, J = 3.6, 7.2 Hz), 3.58 (6H,
dd, J = 7.2, 9.6 Hz); 13C-NMR (100 MHz, CDCl3): "= 138.2, 128.5, 127.8, 127.7, 74.8, 71.7, 71.0; LRMS
(ESI+): m/z (%) = 516 (35), 515 ([M+Na]+, 100); HRMS (ESI+): calcd for C30H36NaO6: 515.2404; found:
515.2421.
Cs symmetric 1,5,9-O-Tribenzyl-3,7,11-trioxacyclododecane-1,7,11-triol (1-Cs). Yield: 55% as a
colorless oil; Rf = 0.48 (hexane/EtOAc, 3/2): IR (neat, cm!1): 2865, 1605, 1497, 1454, 1355, 1305, 1263,
1
1207, 1090, 1073, 1027, 954, 908, 819, 733, 695; H NMR (400 MHz, CDCl3): "= 7.28-7.17 (15H, m),
4.53 (6H, s), 3.70-3.47 (15H, m); 13C-NMR (100 MHz, CDCl3): "= 138.1, 128.4, 127.8, 127.7, 74.6, 74.3,
71.7, 70.4, 69.9, 69.6; LRMS (ESI+): m/z (%) = 516 (32), 515 ([M+Na]+, 100); HRMS (ESI+): calcd for
C30H36NaO6: 515.2404; found: 515.2425.
C3-symmetric 1,5,9-Trioxacyclododecane-3,7,11-triol (5-C3). A solution of 1-C3 (43.5 mg, 0.088
mmol) in THF/EtOH (1/2, 6 mL) was hydrogenated over 10% Pd-C (88 mg) for 25 h at rt. Filtration and
concentration afforded a pale brown solid, which was purified silica gel column chromatography
(CH2Cl2/MeOH = 9/1) to give 5-C3 (18.2 mg, 0.082 mmol, 93%) as an oil: Rf = 0.39 (CH2Cl2/MeOH,
1
4/1); IR (neat, cm!1): 3308, 2868, 1726, 1653, 1460, 1361, 1261, 1138, 1067, 979; H NMR (400 MHz,
CD3OD): "= 3.81 (3H, ddd, J = 3.5, 7.0, 10.4 Hz), 3.67 (6H, dd, J = 3.5, 9.7 Hz), 3.50 (6H, dd, J = 7.0,